Navigation Links
Sphere Fluidics: Expanding Executive Team for Growth of New Market Opportunity
Date:12/10/2013

CAMBRIDGE, England, December 10, 2013 /PRNewswire/ --

Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization and provides proprietary products and novel services for this rapidly-growing market. This enabling approach can find rare variants in large cell populations and Sphere Fluidics has patented novel Cyto-Mine™ technology that permits up to one billion assays per biochip per day. Their technology provides significant operational benefits for biopharmaceutical discovery and development, cancer variation studies, analysis of antibiotic-resistance mutants and identification of novel enzymes and synthetic biology pathways. Sphere Fluidics completed a funding round of circa $3 million earlier this year and has now moved into a larger facility nearby to Cambridge (UK) to enable growth.

     (Logo: http://photos.prnewswire.com/prnh/20131210/658625)

The firm has used the funding to recruit new technical staff, a Commercial Director and has now hired a new R&D Director (Dr Marian Rehak). Dr Rehak previously held Senior R&D positions with Unipath and DxTech, has more than 20 years in Life Sciences R&D and has been hired to help grow the business. "I am excited to be joining the Sphere Fluidics team at this crucial time. We will now not only provide enabling R&D Services, but also develop and launch new Products (e.g. novel instrumentation systems) for single cell analysis," says Dr. Rehak. "Our systems will not only enabling for discovery and development of diverse biopharmaceuticals, but has also created excitement in the emerging field of synthetic biology," he states.

Sphere Fluidics now has almost 120 different, international organizations buying their products. These include leading pharmaceutical companies, Life Sciences biotechsa nd well-known research institutions. The Company has also recently signed several, new collaborative R&D agreements with a number of Blue Chip pharmaceutical companies in an acceleration of their Service business.

"The Company has recently completed comprehensive, market analysis to ensure that our new instrumentation systems were defined by the customer base and are targeted into major global markets," says Dr Frank F. Craig (CEO). "Dr Rehak is part of our plan to rapidly grow the R&D function and our select markets. We welcome him into the Company and look forward to his contribution to our continued success."

Press Contact
Sphere Fluidics Limited.
Contact Dr Frank F. Craig on:
E-mail: Frank.Craig@spherefluidics.com
Tel: +44(0)1223-804201


'/>"/>
SOURCE Sphere Fluidics Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CryoLife Completes Acquisition of Hemosphere
2. PhytoSPHERE Systems, a Medical Marijuana Inc Portfolio Company, to Bring Production Facilities to Europe through Canipa Holdings.
3. Medical Marijuana Inc.s Subsidiary, PhytoSPHERE Systems, Signs the Largest Production Contract in Company History Valued at $7.5 Million
4. Presentation of Possible "Fountain of Youth" Pill Creating "Celebrity" Atmosphere at San Antonio Scientific Conference
5. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems, LLC Cites Broad Applications of its 2013 Harvest of Uniquely Valuable Hemp Oil
6. Sphere Fluidics Successfully Closes a $2.5 million Series A Investment Round
7. Life Technologies Partners with Ridom and Releases SeqSphere+ Software to Speed and Simplify Bacterial Typing
8. PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
9. Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"!
10. Sphere Fluidics: beschleunigtes Wachstum, um die Ausnahme zu finden!
11. MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... CarpalAID is a revolutionary new product that relieves painful ... Carpal tunnel syndrome affects more than 8 million people a year. ... men. The common methods of treating CTS are painful surgery, the ... or gloves. ... CarpalAID is a clear patch worn on the palm of ...
(Date:7/11/2017)... 2017  The global market for liquid biopsy diagnostic ... million in 2016.  Although in early stages, the global ... particular as a result of the gradual shift towards ... introduction of a significant number of new liquid biopsy ... tumor biomarkers to guide treatment decisions. ...
(Date:7/10/2017)... , July 10, 2017  US medical equipment and ... 2021, according to Medical Equipment & Supplies: ... Freedonia Focus Reports. Continued increases in demand for medical ... of the population and supported by gains in disposable ... and supplies. New product introductions will also drive sales ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... Sharon Kleyne, host of the nationally ... on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the air about an ... China. , The article by Zidor Aldama described the situation in which Chinese children ...
(Date:7/24/2017)... CUMBERLAND, PA (PRWEB) , ... July 24, 2017 ... ... by 2030, today CURE announced that they have enrolled over 100,000 children in ... 158,000 afflicted children born every year in areas where treatment is limited or ...
(Date:7/24/2017)... ... July 24, 2017 , ... Advanced Dermatology, P.C. ... York, (516) 784-5858. The office opened earlier this summer and is currently accepting ... Fruma Leah Wiederman. , Advanced Dermatology, P.C. founder and medical director Dr. ...
(Date:7/24/2017)... ... ... The Center for Addiction Recovery Training (CART), the training ... Multiple Pathways of Recovery Conference on October 23-26, 2017. This year, the conference ... principle – a belief in multiple pathways of recovery, aims to bring many ...
(Date:7/23/2017)... CANADA (PRWEB) , ... July 23, 2017 , ... ... of single sport specialization is critical, say researchers presenting their work today at ... Toronto, Canada. , “Our study is the first one to prospectively document ...
Breaking Medicine News(10 mins):